WA 335 (danitracen): a preliminary evaluation of a potential antidepressant compound. A comparative double-blind study with WA 335 and amitriptyline in the treatment of depressive patients.

Source:http://linkedlifedata.com/resource/pubmed/id/401705

Download in:

View as

General Info

PMID
401705